Breast/Ovarian Cancer
__________________________________________________________________
Study Name
Genetic Modifiers of BRCA1 and BRCA2 in Mutation
Carriers (GEMS)
| |
Recruitment Currently Closed Stay Turned for Future Studies |
Description
This multi-center Breast Cancer Study will
recruit approximately 1000 women who have had breast cancer and were tested for
an inherited alteration in the BRCA1 and/or BRCA2 genes. Individuals are
eligible if their test results were either positive or negative.
Alterations in these genes increase the chance of developing breast and ovarian
cancer. This type of research may lead to improved diagnosis, improved
treatment, and possibly, prevention of inherited cancers.
Eligible
candidates must:
- Be 18 years of age or older
- Have a diagnosis of invasive
or in situ (DCIS) breast cancer
- Be tested for a BRCA1 and/or
BRCA2 mutation either prior to the breast cancer diagnosis or no more than 3
years after the breast cancer diagnosis
Participants
will:
- complete a 30-40 minute
questionnaire about medical history and health habits
-
sign a medical records release form for review of
medical information and gene testing
- provide a blood sample
- review and sign a study
consent form
Principal Investigator
Kala Visvanathan, M.D.
Contact Information
Jennifer Axilbund, MS, CGC
Study Coordinator/Genetic Counselor
(410) 614-0378 or 1-877-880-6188
